Latest Articles

Publication Date
Opioid-sparing by low-dose ketamine for endometriosis surgery. A single-center, prospective, randomized, trial.

Endometriosis affects 10% of women of childbearing age and 25-50% of infertile women worldwide. Although most patients with endometriosis are completely asymptomatic, there is still a significant proportion of patients, …

Published: Jan. 18, 2026, midnight
Best 5 City-Friendly Electric Cars in 2026 – Compact Size, Range & Charging Ease - Timesbull

Best 5 City-Friendly Electric Cars in 2026 – Compact Size, Range & Charging Ease Timesbull

Published: Jan. 17, 2026, 5:33 a.m.
Dhurandhar 2: Aditya Dhar Confirms Release Date; Know When Ranveer Singh-Starrer Hits The Theatres? - The Daily Jagran

Dhurandhar 2: Aditya Dhar Confirms Release Date; Know When Ranveer Singh-Starrer Hits The Theatres? The Daily Jagran

Published: Jan. 16, 2026, 10:35 p.m.
Endometriosis as a Systemic and Complex Disease: Toward Phenotype-Based Classification and Personalized Therapy.

Endometriosis is traditionally conceptualized as a pelvic lesion-centered disease; however, mounting evidence indicates it is a chronic, systemic, and multifactorial inflammatory disorder. This review examines the molecular dialog between ectopic …

Published: Jan. 16, 2026, midnight
Collision tumor of endometrial hepatoid adenocarcinoma and endometrial stromal sarcoma: a rare case and literature review.

Endometrial hepatoid adenocarcinoma (HAC) is an exceedingly rare tumor. Histologically, the tumor is predominantly characterized by HAC with additional components, as documented in previous reports. The coexistence of endometrial HAC …

Published: Jan. 16, 2026, midnight
Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch - Yahoo Finance

Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch Yahoo Finance

Published: Jan. 15, 2026, 2:34 a.m.
Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch - MarketBeat

Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch MarketBeat

Published: Jan. 15, 2026, 2:10 a.m.
Blood Test for Endometriosis: New Update on MicroRNA Research Released - markets.businessinsider.com

Blood Test for Endometriosis: New Update on MicroRNA Research Released markets.businessinsider.com

Published: Jan. 14, 2026, 10:59 a.m.
Blood Test for Endometriosis: New Update on MicroRNA Research Released - FinancialContent

Blood Test for Endometriosis: New Update on MicroRNA Research Released FinancialContent

Published: Jan. 14, 2026, 4:16 a.m.
Investigation of endothelin-1 receptor antagonist bosentan in a rat endometriosis model.

The study aimed to investigate the roles of endothelin-1 and endothelin receptors in a rat endometriosis model and to demonstrate how bosentan (BOS), an endothelin receptor blocker, could potentially serve …

Published: Jan. 14, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!